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Abstract 
Background- The prevalence for chronic kidney disease (CKD) in dogs varies widely (0.05% - 
3.74%). Identified risk factors include advancing age, specific breeds, small body-size and 
periodontal disease.  
Hypothesis/Objectives- To estimate the prevalence and identify risk factors associated with 
CKD diagnosis and survival in dogs. Purebred dogs were hypothesised to have higher CKD risk 
and poorer survival characteristics than crossbred dogs. 
Animals- A merged clinical database of 107,214 dogs attending 89 UK veterinary practices over 
a 2-year period (January 2010-December 2011). 
Methods- A longitudinal study design estimated the apparent prevalence (AP) while the true 
prevalence (TP) was estimated using Bayesian analysis. A nested case-control study design 
evaluated risk factors. Survival analysis used the Kaplan-Meier survival curve method and 
multivariable Cox proportional hazards regression modeling. 
Results- The CKD AP was 0.21% (95% CI: 0.19-0.24%) and TP was 0.37% (95% posterior 
credibility interval 0.02-1.44%). Significant risk factors included increasing age, being insured 
and certain breeds (Cocker Spaniel, Cavalier King Charles Spaniel). Cardiac disease was a 
significant co-morbid disorder. Significant clinical signs included halitosis, weight loss, 
polyuria/polydipsia, urinary incontinence, vomiting, decreased appetite, lethargy and diarrhea. 
The median survival time from diagnosis was 226 days (95% CI 112-326 days). IRIS stage and 
blood urea nitrogen concentration at diagnosis were significantly associated with hazard of death 
due to CKD.  
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Conclusions and clinical importance- CKD compromises dog welfare. Increased awareness of 
CKD risk factors and association of blood biochemistry results with survival-time should 
facilitate diagnosis and optimize case management to improve animal survival and welfare. 
 
 
Introduction 
Chronic kidney disease (CKD) is defined as the presence of structural or functional 
abnormalities of one or both kidneys that have been present for an extended period, usually 3 
months or longer 
1
.  Despite being initiated by a heterogeneous variety of familial, congenital 
and acquired factors, the end result of canine CKD is a reduced total kidney glomerular filtration 
rate and the consequences of this to homeostasis 
2
. CKD is said to be the most common kidney 
disease in dogs 
3
 but estimates of prevalence vary widely depending on the source population 
and the case inclusion criteria from  0.05% 
4
, 0.9% 
3
, 0.5-1.5% 
5
 to 3.74% 
6
. 
Studies reporting apparent prevalence values reflect the prevalence of clinical diagnoses but fail 
to account for the often unknown effects of false positive and false negative results. Bayesian 
statistical techniques incorporate such uncertainty and variability by analyzing  estimated 
sensitivity and specificity distributions for clinical diagnosis to derive true prevalence values 
with appropriate confidence intervals 
7
.  
Although CKD is ultimately a progressive disorder, early diagnosis and management may 
modify the rate of progression and improve patient quality and quantity of life 
8-11
. Demographic 
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risk factors previously identified for CKD include advancing age
4,6,12,13
 , small size 
14
 and 
specific breeds with familial kidney disease including the Chinese Shar Pei
15
, Bull Terrier 
16
, 
English Cocker Spaniel 
17
, West Highland White Terrier 
18
 and Boxer 
19
. Periodontal disease has 
been identified as a clinical risk factor for CKD 
14,20
.  
The International Renal Interest Society (IRIS) has proposed a progressing 4-stage scoring 
system for canine CKD based on blood biochemical testing, urinalysis results and systemic 
arterial blood pressure 
21
 that categorizes CKD cases to facilitate diagnosis, treatment, prognosis 
and research 
22
. Clinically affected dogs present at various points along the IRIS stages 
1
 but the 
majority of CKD cases ultimately converge to the uraemic state, characterized by multiple severe 
physiologic and metabolic derangements of impaired kidney function 
3
.  Dogs in IRIS stages 3 
and 4 survive from a few months to 2 years with most dying or being euthanized because of their 
disease 
1
.  
The primary objectives of this study were to estimate the prevalence of CKD among dogs 
attending UK primary care veterinary practices, to identify demographic and clinical risk factors 
associated with CKD diagnosis and survival and to describe survival characteristics following 
diagnosis.  Purebred dogs were hypothesised to experience higher CKD risk and poorer survival 
characteristics than crossbred dogs.  
Materials and Methods 
A longitudinal study design followed dogs attending participating practices over time and 
estimated the prevalence of CKD diagnosis in dogs from all electronic patient records (EPRs) 
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between 1
st
 January  2010 and 31
st
 December 2011 within the VetCompass Animal Surveillance 
project 
23
. Practices were selected by willingness to participate and were mainly in central and 
south-eastern England. A nested case-control study design evaluated risk factors associated with 
CKD diagnosis and survival. Control animals were selected using a web-based random number 
generator 
24
 with exclusion of animals having a history indicative of kidney disease. Sample size 
calculations 
25
 estimated an unmatched case-control study with 209 cases and 209 controls  
would have  an  80% power to detect a risk factor with an odds ratio of 2.0 or greater (two-sided 
=0.05) having a 15% prevalence in the control animals.  
Summary diagnosis terms from the VeNom Code list of veterinary-specific terms were recorded 
at episodes of clinical care 
26
. EPRs were extracted using an integrated clinical query 
27
 and 
uploaded to a secure structured query language (SQL) database. Clinical fields shared included 
unique clinic and animal identification numbers, birth-date, species, breed, sex, neuter status, 
insured status, consultation date, bodyweight, clinical notes, summary diagnosis term and 
treatment details. Ethics approval was granted by the Royal Veterinary College Ethics & Welfare 
Committee (reference number 2010 1076). 
Dog breeds were sub-categorized for analysis using three systems: purebred/crossbred; breed 
Kennel Club (KC) status (registered/not registered) and breed KC group status (gundog, hound, 
pastoral, terrier, toy, utility, working) 
28
. Breeds with 12 or more dogs within the case:control 
part of the study were evaluated separately (Table 1). The final recorded weight, insurance and 
neuter status was included for analysis. The age at the final live record was included for the case-
control study while the age at diagnosis was used for survival analysis. Age (years) was 
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categorized into 4 rounded quantiles; <4, 4-7, 7-12 and >12 while weight (kg) was categorized 
into 5 rounded quantiles: <7, 7-11, 11-20, 20-30, and >30. Clinical laboratory results were 
available only when transcribed by practitioners to the clinical notes.  Cases with available blood 
creatinine concentration (mg/dl) at diagnosis were staged using  IRIS guidelines; Stage 1: <1.4, 
Stage 2: 1.4-2.0, Stage 3: 2.1-5.0, Stage 4: >5.0 with Stage 1 and 2 collapsed for analysis 
21
. 
Dogs with blood urea nitrogen concentration (mg/dl) available at diagnosis were categorized into 
4 groups: <44.8, 44.8 to <64.4, 64.4 to <112.0 and ≥112.0.  
Preliminary CKD case identification used VeNom diagnosis terms (chronic kidney (renal) 
disease, renal (kidney) disorder) and free-text searching of clinical notes (renal, kidney, CKD, 
CRD, CKF, CRF, azot*, urem*, uraem*). The CKD case definition relied on primary 
practitioner diagnosis based on clinical acumen and synthesis of their medical knowledge of the 
animal including anamnesis, physical examination and laboratory testing that was not necessarily 
formally recorded within the clinical notes. Specifically, case inclusion criteria required both i) a 
summary diagnosis term, insurance claim term or free-text diagnosis of CKD with a consistent 
history and ii) evidence that  blood biochemistry analysis assisted the diagnosis process. CKD 
diagnosis date was defined as the first drawing of a confirmatory blood sample. Where diagnosis 
preceded available records, prior clinical histories (n=15) were sourced. Clinical laboratory 
values (creatinine, urea, phosphate) at diagnosis and urinalysis results obtained closest to the 
diagnosis date (maximum 28-day window) were recorded.  Dates for the earliest and latest live 
animal EPR, all documented clinical signs and co-morbid disorders and, for animals dying 
during the study, the cause of death (if natural) or stated reason for euthanasia were recorded.  
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Following spreadsheet checking and cleaning (Microsoft Office Excel 2007, Microsoft Corp.), 
all analysis used Stata Version 11.2 (Stata Corporation) except for true prevalence (TP) 
estimation.  Bayesian analysis implemented in OpenBUGS version 3.2.1 rev 781 
29,30
 derived TP 
based on a non-informative prevalence prior, the estimated AP and expert opinion provided by 
one of the authors (JE) for primary practice diagnostic sensitivity (Se) (the proportion all true 
CKD cases that are correctly diagnosed as CKD) and diagnostic specificity (Sp) (the proportion 
of all true non-CKD animals that were correctly classified as non-CKD) values. Low Se (20%, 
with 95% confidence of being under 33%) and high Sp (99.5%, with 95% confidence of being 
above 98%) values were selected because of the expense and complexity of CKD diagnosis and 
the case definition used 
31
.  Beta prior distributions were parameterized using the BetaBuster 
program  
32
.  
Demographic risk factors with a P-value <0.20 in univariable logistic regression and purebred 
status (variable of a priori interest) were evaluated using multivariable logistic regression. Model 
building used manual backwards elimination. All eliminated factors were re-evaluated for 
confounding effects within the provisional-final model before confirming their removal.  
Biologically meaningful pairwise interactions were assessed between the final model variables. 
An effect of clustering at the clinic level was evaluated in the final model using the clinic 
attended as a random effect 
33
. Model fit diagnostics were evaluated (Hosmer and Lemeshow 
2000). Statistical significance was set at P=0.05. The univariable association between CKD and 
purebred/crossbred status for dogs less than 5 years old was additionally evaluated using Fisher’s 
exact test 
34
. 
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Co-morbid disorders and clinical signs univariably associated with CKD (P<0.20) were 
evaluated for adjusted association (P<0.05) by individual addition to the final demographic 
multivariable regression model. For complete separation (zero-cells), the Stata firthlogit program 
allowed inference based on the profile penalized likelihood 
35
. 
Median survival time from diagnosis was estimated using the Kaplan-Meier method with 
differences between categories evaluated by the log-rank test. Explanatory variables with P<0.20 
in univariable Cox proportional hazards regression models and purebred status were assessed 
using multivariable Cox modelling. Model fitting used a manual backwards elimination approach 
with significance set at P<0.05. The proportionality assumption was tested using Schoenfeld and 
scaled Schoenfeld residuals and the fit of the final model to the data was checked using Cox-
Snell residuals. 
 
Results 
Overall, 228 dogs met the CKD inclusion criteria from 107,214 dogs attending 89 practices. The 
CKD AP was 0.21% (95% CI: 0.19-0.24%). Using Bayesian inference, the CKD TP was 
estimated to be 0.37% (95% posterior credibility interval 0.02-1.44%).  
Of the case dogs, 190/228 (83.3%) were purebred, 115/228 (50.4%) were female, 173/228 
(75.9%) were neutered, 126/227 (55.5%) were insured and 145/228 (63.6%) were aged over 12 
years at diagnosis. The most frequently affected breeds were the Yorkshire Terrier, Jack Russell 
Terrier and West Highland White Terrier (Table 1). At diagnosis, 95/136 dogs (69.9%) were 
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IRIS Stage 3 or 4 while 37/139 (26.6%) had blood urea nitrogen concentrations at or above 112.0 
mg/dl/l.  During the study period, 118/228 (51.8%) dogs died of CKD with 99/118 (83.9%) of 
these being euthanized.  
Risk factor analysis 
The variables taken forward from univariable analysis but not retained following multivariable 
modeling included purebred status (a priori interest), neuter status and bodyweight category 
(Table 1). Demographic risk factors significantly associated with a diagnosis of CKD included 
age group, insured status and breed (Table 2). The results of multivariable analysis indicated that 
dogs aged 12 years and above had 5.49 (95%CI: 2.84-10.60, P<0.001) times the odds and dogs 
aged between 4 and 7 years had 0.22 (95%CI: 0.10-0.48, P<0.001) times the odds of CKD 
compared with dogs aged between 7 and 12 years. Insured animals had 2.55 (95%CI: 1.50-4.33, 
P<0.001) times the odds of CKD of uninsured dogs. Cocker Spaniels (odds ratio (OR) 6.39, 
95%CI: 1.63-25.00, P=0.008) and Cavalier King Charles Spaniels (CKCS) (OR 5.57, 95%CI: 
1.07-28.97, P=0.041) had increased odds of CKD compared with crossbreds. Clustering within 
the veterinary clinic attended did not improve the model (P = 0.4273). No significant interactions 
were found. The Hosmer-Lemeshow test indicated good model fit (P=0.7285).  The area under 
ROC curve was 0.8783, indicating excellent CKD discrimination 
36
. 
For dogs aged less than 5 years, purebred/crossbred status was not associated with CKD 
(P=0.218).  
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Co-morbid disorders and clinical signs 
The most frequent CKD co-morbid disorders recorded were gingivitis/periodontitis (69 cases, 
30.3%), cardiac disorders (68, 29.8%) and musculoskeletal disorders (56, 24.6%). Following 
adjustment, disorders significantly associated with CKD included hypertension (OR: 25.71, 95% 
CI 1.38-479.20, P<0.001) and cardiac disease (OR: 3.88, 95%CI 1.69-8.90, P<0.001) (Table 
3).The most frequent clinical signs of CKD cases were vomiting (114 dogs, 50.0%), 
polyuria/polydipsia (100, 43.9%) and appetite decreased/anorexia (90, 39.5%). Significantly 
associated clinical signs included halitosis (OR: 57.03, 95%CI 3.16-1030.50, P<0.001), anaemia 
(OR: 40.71, 95%CI 2.00-827.66, P<0.001), weight loss/cachexia (OR: 12.89, 95%CI 4.81-34.55, 
P<0.001), polyuria/polydipsia (OR: 7.70, 95%CI 3.53-16.82, P<0.001), urinary incontinence 
(OR: 4.97, 95%CI 1.72-14.37, P<0.001) and vomiting (OR: 4.57, 95%CI 2.53-8.24, P<0.001) (  
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Table 3). 
Survival analysis 
Using a Kaplan-Meier survival curve, the median survival time from CKD diagnosis until death 
due to CKD (including euthanasia) was 226 days (95% CI 112-326 days). No demographic 
variables were significantly associated with survival differences but IRIS stage (P<0.001) 
(Figure 1) and blood urea nitrogen concentration (P<0.001) (Figure 2) were significantly 
associated.  
No demographic variables were significant in univariable Cox regression analysis. Blood 
phosphate concentration, urine specific gravity at diagnosis and purebred status were taken 
forward to Cox multivariable modeling but not retained. The final Cox regression model 
included IRIS stage and urea nitrogen concentration (Table 4). Compared with IRIS Stage 1 and 
2 combined, dogs in IRIS Stage 3 at diagnosis showed 2.62 (95% CI 1.14-6.01, P=0.023) times 
and dogs in IRIS Stage 4 had 4.71 (95%CI 1.74-12.72, P=0.002) times the hazard of death from 
CKD. Dogs with blood urea nitrogen concentrations of 112.0 mg/dl or greater at diagnosis had 
7.76 (95% CI 2.65-22.74, P<0.001) times the hazard of death from CKD compared with those 
with blood urea nitrogen concentrations below 44.8 mg/dl. There was no evidence of interaction 
in the final model. The model assumptions were met and the model fitted the data adequately. 
 
Discussion 
This large study of dogs attending UK practices showed a relatively low but clinically relevant 
CKD prevalence (AP 0.21%, Bayesian TP 0.37%) and identified increased diagnosis among 
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older and insured dogs as well as certain breeds. Cardiac disease was significantly associated 
with CKD.  Additional consideration of halitosis and urinary incontinence as diagnostically-
predictive clinical signs should improve diagnostic sensitivity. IRIS staging and blood urea 
nitrogen concentrations at diagnosis enhanced prognostic prediction. Purebred dogs did not show 
higher CKD risk or poorer survival than crossbreds, either overall or within dogs aged below 5 
years.   
The CKD prevalence indicated by this study is at the lower end of the reported 0.05-3.74% 
spectrum from previous studies 
3-6
 which were based on varying denominator population 
calculations and CKD definitions.  Prevalence estimates derived from referral caseloads are 
likely to poorly represent the overall population and to over-represent CKD prevalence 
37
.  CKD 
case definitions in earlier studies ranged from just a single blood biochemical analysis and 
urinalysis 
4
 to repeated blood biochemistry analysis with renal histopathology and 
ultrasonography 
6
.  The current analysis used the entire known study population as the 
denominator and the case definition reflected primary practice diagnostic norms to ensure 
relevance for primary practitioners.   
Most prevalence studies report apparent prevalence (prevalence of diagnoses made) rather than 
true prevalence (prevalence of all true cases) because of imperfect clinical tests 
38
. Within a 
clinical environment, all animal evaluations (including clinical examinations and laboratory 
tests) can be considered diagnostic tests and combinations of these tests could be considered as 
an overall CKD diagnosis test. The consequences of test errors include false negative (true cases 
that are missed) and false positives (non-cases that are diagnosed as cases). Although rare, where 
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diagnostic sensitivity and specificity are known, true prevalence can be calculated by formulaic 
adjustment within the frequentist statistical paradigm 
33
. Bayesian analytic methods are 
increasingly applied to veterinary epidemiologic data to formally incorporate prior information 
and expert opinion into prevalence calculations 
31
 and to estimate the true prevalence of disease. 
The current study results estimated CKD true prevalence (TP) (0.37%) to be almost twice as high 
as the apparent prevalence (AP) (0.21%), suggesting failure to reach a final diagnosis in a 
substantial proportion of cases.  It should be noted that the Bayesian estimates included expert 
opinion for Se and Sp values. An inconsistent opinion would have yielded differing results.  
Elucidation of demographic and clinical CKD risk factors could improve diagnostic sensitivity 
and timeliness 
39
 and optimize primary-cause and conservative case management with  
consequent animal welfare gains
9
. Demographic CKD risk factors identified in this study 
included advancing age, being insured and specific breeds. Dogs older than 12 years had over 5 
times the odds of CKD compared with dogs aged 7-12 years, concurring with several previous 
reports 
3,5,40
 and supporting the theory of CKD progression from early subclinical kidney damage 
to clinical disease 
40
.  
Non-insured animals were less than half as likely to receive a CKD diagnosis as insured animals, 
agreeing with Swedish pet insurance analysis where non-insured animals were believed to access 
veterinary care less often and undergo fewer medical procedures such as blood tests compared 
with insured animals 
41
. Given that the recommended minimum CKD clinical database includes a 
range of hematology, blood biochemistry and urinalysis tests 
42
, these results suggest financial 
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constraints to diagnosis are compromising dog welfare and partially explain imperfect diagnostic 
sensitivity.   
Familial renal disease generally results in CKD before 5 years of age 
43
. Purebred dogs did not 
show increased CKD odds, either overall or for dogs aged below 5 years, or increased hazard 
compared with crossbred dogs. Hybrid dogs are stated to generally grow bigger and stronger 
than their purebred parents 
44
 and it was hypothesised that crossbred health would benefit from 
this hybrid vigor effect 
45
 combined with reduced familial effects.  Many UK crossbred dogs are 
purebred hybrids with recognizable phenotypes from one or more genealogical breeds and may 
retain inbreeding depression effects of the parental breeds 
46
. Specific canine hybrid breeding 
programs are growing in popularity but further studies on diverse disorders and with larger case 
numbers are needed to establish the true extent of any suggested hybrid health benefits 
47
. Other 
reported breed-related causes of CKD (e.g. cardiovascular 
48
, immunologic 
4
, neoplasia 
49
, renal 
calculi 
50
) could  have contributed to the  Cocker Spaniel and CKCS breed predispositions 
identified. The CKD odds ratio increased from univariable to multivariable analysis for the 
Cocker Spaniel (1.73 to 6.39) and CKCS (2.72 to 5.57) because of the younger age distribution 
and lower insurance status for these breeds relative to many other breeds analysed (data not 
shown). This highlights improved interpretation resulting from multivariable analyses that 
account for confounding effects within epidemiological studies.   
Vigilance for co-morbid disorders that worsen the CKD condition may improve the situation by 
appropriate management 
8
 as well as increasing diagnostic sensitivity. Cardiac disease remained 
significantly associated with CKD following adjustment for age, insurance and breed. Renal 
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impairment has previously been shown to increase with the severity of congestive heart failure 
and to be a frequent finding in dogs with chronic valvular disease 
51
. The low prevalence of 
hypertension (6.1%) identified among CKD cases contrasts with the 50-93% level reported by 
Bartges et al.
52
 and may reflect sub-optimal use of blood pressure monitoring among primary 
practice caseloads.  
Although previously identified as an important predictor for canine CKD
14
, the current study did 
not identify an association with smaller body size. Despite affecting over 30% of CKD cases, 
gingivitis/periodontitis was not a significant risk factor because of its widespread occurrence; 
19.5% (95% CI: 20.0-20.9%) of US private practice dogs were reported to show gingivitis
53
.  
Distressing clinical signs are believed to indicate suffering but there is no current system to rank 
their welfare impact 
54
. This study re-affirms several previously reported and unpleasant CKD 
clinical signs (weight loss, polyuria/polydipsia, anaemia, urinary incontinence, vomiting and 
diarrhea
2,3,14
) establishing CKD as a disorder that can compromise dog welfare appreciably.  
Counseling owners on the clinical relevance of these signs, especially halitosis
14
, should 
encourage earlier presentation and diagnosis
55
 with consequent enhancements to life quality and 
quantity
8
.   
Increasing IRIS stage and blood urea nitrogen concentration at diagnosis were both associated 
with decreased survival time. Formal IRIS staging recommendations include assessment of 
fasting plasma creatinine concentrations on at least two occasions in the stable patient, with sub-
staging based on proteinuria and systemic blood pressure. The current study adapted these 
guidelines by staging from a single creatinine measurement at diagnosis to reduce selection bias 
17 
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and reflect primary practice diagnostic protocols. The survival effects associated with IRIS 
stages supports their in-practice use for CKD case management and prognosis 
21
.   
There were some limitations to the current study. Although practice selection was a convenience 
sample mainly in central and south-east England, the high number of participating practices (89) 
should assure generalisability. Clinical laboratory results were available only when transcribed to 
the clinical notes, introducing possible transcription error and bias. The inclusion of co-morbid 
disorder diagnoses relied upon the attending veterinarian detecting and recording the concurrent 
disease. The performance and results of positive tests (e.g. a dog has hypertension) may be more 
likely to be recorded than information related to tests that are found to be negative (e.g. a dog 
does not have hypertension). Case notes without a recorded co-morbid disorder did not 
necessarily imply that the animal was either evaluated or tested negative for this disorder.   
CKD in dogs is an important welfare disorder because of its clinically relevant prevalence, 
unpleasant clinical signs and impact on case survival. Increased awareness of the demographic 
and clinical risk factors identified in this study should lead to earlier and improved diagnosis 
with optimized case management for improved survival and animal welfare. The interpretation 
of blood biochemistry results should improve the accuracy of prognostic estimation for 
individual cases.  
 
18 
 
18 
 
References 
1.  Polzin DJ. Chronic Kidney Disease in Small Animals. Veterinary Clinics of North America: 
Small Animal Practice 2011;41:15-30. 
2.  Nelson RW, Couto CG. Small animal internal medicine, 4th ed. ed. Edinburgh: Mosby; 2009. 
3.  Polzin DJ, Osborne CA, Ross S. Chronic Kidney Disease. In: Ettinger SJ, Feldman EC, eds. 
Textbook of veterinary internal medicine : diseases of the dog and cat, 6th ed. / Stephen J. 
Ettinger, Edward C. Feldman. ed. St. Louis, Miss. ; Oxford: Elsevier Saunders; 2005:1756-1785. 
4.  Macdougall DF, Cook T, Steward AP, et al. Canine chronic renal disease: Prevalence and 
types of glomerulonephritis in the dog. Kidney Int 1986;29:1144-1151. 
5.  Brown SA. Management of chronic kidney disease. In:  BSAVA manual of canine and feline 
nephrology and urology. editors, Jonathan Elliott and Gregory F. Grauer, 2nd ed. ed. Quedgeley: 
British Small Animal Veterinary Association; 2007:223-230. 
6.  Sosnar M. Retrospective study of renal failure in dogs and cats admitted to University of 
Veterinary and Pharmaceutical Sciences Brno during 1999-2001. Acta Veterinaria Brno 
2003;72:593-598. 
7.  Gardner IA. The utility of Bayes' theorem and Bayesian inference in veterinary clinical 
practice and research. Australian Veterinary Journal 2002;80:758-761. 
8.  Bartges JW. Chronic Kidney Disease in Dogs and Cats. Veterinary Clinics of North America: 
Small Animal Practice 2012;42:669-692. 
9.  Lees GE. Early Diagnosis of Renal Disease & Renal Failure. Veterinary Clinics of North 
America Small Animal Practice 2004;34:867-885. 
19 
 
19 
 
10.  Grauer GF. Early detection of renal damage and disease in dogs and cats. Veterinary Clinics 
of North America, Small Animal Practice 2005;35:581-596. 
11.  Tenhündfeld J, Wefstaedt P, Nolte IJA. A randomized controlled clinical trial of the use of 
benazepril and heparin for the treatment of chronic kidney disease in dogs. Journal of the 
American Veterinary Medical Association 2009;234:1031-1037. 
12.  Müller-Peddinghaus R, Trautwein G. Spontaneous Glomerulonephritis in Dogs: II. 
Correlation of Glomerulonephritis with Age, Chronic Interstitial Nephritis and Extrarenal 
Lesions. Veterinary Pathology Online 1977;14:121-127. 
13.  Vaden SL. Glomerular Disease. Topics in Companion Animal Medicine 2011;26:128-134. 
14.  Bartlett PC, Van Buren JW, Bartlett AD, et al. Case-Control Study of Risk Factors 
Associated with Feline and Canine Chronic Kidney Disease. Veterinary Medicine International 
2010;2010. 
15.  DiBartola SP, Tarr MJ, Webb DM, et al. Familial renal amyloidosis in Chinese Shar Pei 
dogs. Journal of the American Veterinary Medical Association 1990;197:483-487. 
16.  Jones BR, Gething MA, Badcoe LM, et al. Familial progressive nephropathy in young Bull 
Terriers. New Zealand Veterinary Journal 1989;37:79-82. 
17.  Lees G, Helman R, Homco L, et al. Early diagnosis of familial nephropathy in English 
cocker spaniels. Journal of the American Animal Hospital Association 1998;34:189-195. 
18.  McAloose D, Casal M, Patterson DF, et al. Polycystic Kidney and Liver Disease in Two 
Related West Highland White Terrier Litters. Veterinary Pathology Online 1998;35:77-80. 
19.  Chandler ML, Elwood C, Murphy KF, et al. Juvenile nephropathy in 37 boxer dogs. Journal 
of Small Animal Practice 2007;48:690-694. 
20 
 
20 
 
20.  Glickman LT. Association between chronic azotemic kidney disease and the severity of 
periodontal disease in dogs. Preventive Veterinary Medicine 2011;99:193-200. 
21.  IRIS. International Renal Interest Society (IRIS). In: http://www.iris-
kidney.com/index.shtml Novartis Animal Health Inc.; 2007. 
22.  Elliott J. Staging chronic kidney disease. In: Elliott J, Grauer GF, eds. BSAVA manual of 
canine and feline nephrology and urology. editors, , 2nd ed. ed. Quedgeley: British Small Animal 
Veterinary Association; 2007:161-166. 
23.  VetCompass. VetCompass: Health surveillance for UK companion animals. In: 
http://www.rvc.ac.uk/VetCompassRVC Electronic Media Unit; 2012. 
24.  Haahr M. RANDOM.ORG: True random number service. In: 
http://www.random.org/TSDA; 2012. 
25.  Epi  Info 7 CDC. Centers for Disease Control and Prevention (US): Introducing Epi Info 7. 
In: http://wwwn.cdc.gov/epiinfo/7. Atlanta, Georgia: CDC; 2012. 
26.  The VeNom Coding Group. VeNom Veterinary Nomenclature. In: Group TVC, ed. 
http://www.venomcoding.orgVeNom Coding Group; 2012. 
27.  Upjohn M, Jasani S, Church D, et al. Establishing an Electronic Patient Record (EPR) in 
first opinion veterinary practice: challenges to overcome. In: Society for Veterinary 
Epidemiology and Preventive Medicine (SVEPM), Liverpool 2008;1. 
28.  The Kennel Club. Kennel Club's Breed Information Centre. In: Club TK, ed. 
http://www.the-kennel-club.org.uk/services/public/breed/Default.aspxThe Kennel Club; 2012. 
29.  Thomas A, O’Hara B, Ligges U, et al. Making BUGS Open. R News 2006;6:12-17. 
21 
 
21 
 
30.  Thomas A. OpenBUGS. In: Thomas N, ed. http://www.openbugs.info/w/FrontPage. 
Helsinki: 2009. 
31.  McV Messam LL, Branscum AJ, Collins MT, et al. Frequentist and Bayesian approaches to 
prevalence estimation using examples from Johne's disease. Animal health research reviews / 
Conference of Research Workers in Animal Diseases 2008;9:1-23. 
32.  Su C-L. Bayesian Epidemiologic Screening Techniques: Betabuster. In. Davis, US.: 
Department of Medicine and Epidemiology, University of California, Davis; 2012. 
33.  Dohoo I, Martin W, Stryhn H. Veterinary Epidemiologic Research, 2nd edUniversity of 
Prince Edward Island; 2009. 
34.  Kirkwood BR, Sterne JAC, Kirkwood BREoms. Essential medical statistics, 2nd ed. / Betty 
R. Kirkwood, Jonathan A.C. Sterne. ed. Malden, Mass. ; Oxford: Blackwell Science; 2003. 
35.  Heinze G, Schemper M. A solution to the problem of separation in logistic regression. 
Statistics in Medicine 2002;21:2409-2419. 
36.  Hosmer DW, Lemeshow S. Assessing the fit of the model. In Applied Logistic 
RegressionJohn Wiley & Sons; 2000. 
37.  Bartlett PC, Van Buren JW, Neterer M, et al. Disease surveillance and referral bias in the 
veterinary medical database. Preventive Veterinary Medicine 2010;94:264-271. 
38.  Drobatz KJ. Measures of accuracy and performance of diagnostic tests. Journal of 
Veterinary Cardiology 2009;11:S33-S40. 
39.  Doherr MG, Audigé L. Monitoring and surveillance for rare health-related events: a review 
from the veterinary perspective. Philosophical transactions of the Royal Society of London 
Series B, Biological sciences 2001;356:1097-1106. 
22 
 
22 
 
40.  Bartges J, Polzin DJ. Nephrology and urology of small animals. Oxford: Wiley-Blackwell; 
2011. 
41.  Egenvall A, Nodtvedt A, Penell J, et al. Insurance data for research in companion animals: 
benefits and limitations. Acta Vet Scand 2009;51:42. 
42.  Elliott J, Watson ADJ. Chronic Kidney Disease: Staging and Management. In: Bonagura JD, 
Kirk RW, eds. Kirk's current veterinary therapy. XIV. Philadelphia, Pa. ; London: Elsevier 
Saunders; 2008:883-892. 
43.  DiBartola SP. Chapter 264: Familial Renal Disease in Dogs and Cats. In: Ettinger SJ, 
Feldman EC, eds. Textbook of veterinary internal medicine : diseases of the dog and cat, 6th ed. 
ed. St. Louis, Miss. ; Oxford: Elsevier Saunders; 2005:1819-1824. 
44.  Chen ZJ. Molecular mechanisms of polyploidy and hybrid vigor. Trends Plant Sci 
2010;15:57-71. 
45.  Van Vleck LD, Pollak EJ, Oltenacu EAB. Genetics for the animal sciences. New York: 
W.H. Freeman; 1987. 
46.  Liberg O, Andrén H, Pedersen H-C, et al. Severe inbreeding depression in a wild wolf Canis 
lupus population. Biology Letters 2005;1:17-20. 
47.  Oliver JAC, Gould DJ. Survey of ophthalmic abnormalities in the labradoodle in the UK. 
Veterinary Record 2012;170:390. 
48.  Schiffrin EL, Lipman ML, F.E. Mann JFE. Chronic Kidney Disease: Effects on the 
Cardiovascular System. Circulation 2007;116:85-97. 
23 
 
23 
 
49.  Bronden LB, Nielsen SS, Toft N, et al. Data from the Danish Veterinary Cancer Registry on 
the occurrence and distribution of neoplasms in dogs in Denmark. Veterinary Record 
2010;166:586-590. 
50.  Ling GV, Ruby AL, Johnson DL, et al. Renal calculi in dogs and cats: prevalence, mineral 
type, breed, age, and gender interrelationships (1981-93). Journal of Veterinary Internal 
Medicine 1998;12:11-21. 
51.  Nicolle AP, Chetboul V, Allerheiligen T, et al. Azotemia and Glomerular Filtration Rate in 
Dogs with Chronic Valvular Disease. Journal of Veterinary Internal Medicine 2007;21:943-949. 
52.  Bartges JW, Willis AM, Polzin DJ. Hypertension and renal disease. The Veterinary clinics 
of North America Small animal practice 1996;26:1331-1345. 
53.  Lund EM, Armstrong PJ, Kirk CA, et al. Health status and population characteristics of dogs 
and cats examined at private veterinary practices in the United States. J Am Vet Med Assoc 
1999;214:1336-1341. 
54.  Gregory NG. Physiological Mechanisms Causing Sickness Behaviour and Suffering in 
Diseased Animals. Anim Welfare 1998;7:293-305. 
55.  Marinelli L, Adamelli S, Normando S, et al. Quality of life of the pet dog: Influence of 
owner and dog's characteristics. Applied Animal Behaviour Science 2007;108:143-156. 
 
 
 
24 
 
24 
 
  
25 
 
25 
 
Table 1. Descriptive and univariable logistic regression results for risk markers associated with 
canine chronic kidney disease 
Variable 
Case no. 
(%) 
Control no. 
(%) 
Odds 
ratio 
95% CI P-Value 
Purebred      
 No 38 (16.7) 46 (20.2) Referent Referent Referent 
 Yes 190 (83.3) 182 (79.8) 1.26 0.79-2.03 0.334 
Kennel Club registered 
breed 
    
 
 No 57 (25.0) 66 (28.9) Referent Referent Referent 
 Yes 171 (75.0) 162 (71.1) 1.22 0.81-1.85 0.343 
Breeds (named if ≥ 12 study 
dogs)  
    
 
 Crossbred 38 (16.7) 46 (20.2) Referent  Referent Referent 
 Breeds with <12 study dogs 91 (39.9) 84 (36.8) 1.31 0.78-2.21 0.309 
 Border Collie 10 (4.4) 2 (0.9) 6.05 1.25-29.32 0.025 
 Cavalier King Charles 
Spaniel 
9 (3.9) 4 (1.8) 2.72 0.78-9.54 
0.117 
 Cocker Spaniel 10 (4.4) 7 (3.1) 1.73 0.60-4.98 0.310 
 Jack Russell Terrier 18 (7.9) 17 (7.5) 1.28 0.58-2.82 0.538 
 Labrador Retriever 9 (3.9) 19 (8.3) 0.57 0.23-1.41 0.227 
 Shih Tzu 6 (2.6) 8 (3.5) 0.91 0.29-2.85 0.868 
 Staffordshire Bull Terrier 4 (1.8) 26 (11.4) 0.19 0.06-0.58 0.004 
 Yorkshire Terrier 19 (8.3) 10 (4.4) 2.30 0.96-5.53 0.063 
 West Highland White 
Terrier 
14 (6.1) 5 (2.2) 3.39 1.12-10.26 
0.031 
Sex     
 
 Female 115 (50.4) 106 (46.5) Referent Referent Referent 
 Male 113 (49.6) 122 (53.5) 0.85 0.59-1.23 0.399 
Neuter status     
 
 No 55 (24.1) 114 (50.0) Referent Referent Referent 
 Yes 173 (75.9) 114 (50.0) 3.15 2.11-4.69 <0.001 
Age category     
 
 Less than 4 years 9 (3.9) 114 (50.0) 0.06 0.03-0.14 <0.001 
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 4 to less than7 years 16 (7.0) 42 (18.4) 0.31 0.15-0.62 0.001 
 7 to less than 12 years 58 (25.4) 47 (20.6) Referent Referent Referent 
 12 years and older 145 (63.6) 25 (11.0) 4.70 2.65-8.33 <0.001 
Weight category     
 
 Less than 7kg 39 (17.1) 44 (19.3) Referent Referent Referent 
 7kg to less than 11kg 58 (25.4) 29 (12.2) 2.26 1.21-4.19 0.010 
 11kg to less than 20kg 59 (25.9) 39 (17.1) 1.71 0.95-3.08 0.076 
 20kg to less than 30kg 33 (14.5) 45 (19.7) 0.83 0.44-1.54 0.551 
 30kg and above 26 (11.4) 41 (18.0) 0.72 0.37-1.38 0.315 
Insured status     
 
 No 101 (44.3) 135 (59.2) Referent Referent Referent 
 Yes 126 (55.3) 79 (34.6) 2.13 1.46-3.12 <0.001 
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Table 2. Final multivariable logistic regression model for a primary practice case:control study of 
risk factors associated with canine chronic kidney disease (228 cases and 228 controls) 
Risk Factor Odds Ratio 95% CI P-value 
Age group (years) 
   
 Under 4 0.06 0.03-0.14 <0.001 
 4 to <7 0.22 0.10-0.48 <0.001 
 7 to <12 Referent Referent Referent 
 Over 12 5.49 2.84-10.60 <0.001 
Insured status 
   
 Uninsured Referent Referent Referent 
 Insured 2.55 1.50-4.33 <0.001 
Breeds (named if ≥ 12 study dogs) 
   
 Crossbred Referent Referent Referent 
 Breeds with <12 study dogs 2.58 1.24-5.38 0.011 
 Border Collie  7.65 0.83-70.51 0.073 
 Cavalier King Charles Spaniel* 5.57 1.07-28.97 0.041 
 Cocker Spaniel* 6.39 1.63-25.00 0.008 
 Jack Russell Terrier 1.56 0.54-4.54 0.415 
 Labrador Retriever 0.53 0.16-1.72 0.292 
 Shih Tzu 1.45 0.26-8.07 0.674 
 Staffordshire Bull Terrier 0.84 0.21-3.46 0.815 
 West Highland White Terrier 1.38 0.36-5.27 0.638 
 Yorkshire Terrier  1.47 0.48-4.52 0.506 
*Individual breed with significantly higher CKD odds than crossbreds 
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Table 3. Co-morbid disorders and clinical signs having significant association (P<0.05) with 
canine chronic kidney disease when individually added to a multivariable logistic regression 
model of primary practice dogs that also included age group, insured status and common breed 
variables 
 No. Cases 
(%) 
No. Controls 
(%) 
Odds 
Ratio 
95% C.I. P-Value 
Disorder diagnosed 
 Hypertension* 14 (6.1) 0 (0.0) 25.71 1.38-479.20 <0.001 
 Pancreatitis* 11 (4.8) 0 (0.0) 16.96 0.69-414.01 0.021 
 Cardiac disorder 68 (29.8) 13 (5.7) 3.88 1.69-8.90 <0.001 
Clinical sign 
 Halitosis* 27 (11.8) 0 (0.0) 57.03 3.16-1030.50 <0.001 
 Anaemia* 9 (3.9) 0 (0.0) 40.71 2.00-827.66 <0.001 
 Weight loss/Cachexia 66 (28.9) 6 (2.6) 12.89 4.81-34.55 <0.001 
 Polyuria/Polydipsia 100 (43.9) 10 (4.4) 7.70 3.53-16.82 <0.001 
 Urinary incontinence 45 (19.7) 5 (2.2) 4.97 1.72-14.37 <0.001 
 Vomiting 114 (50.0) 38 (16.7) 4.57 2.53-8.24 <0.001 
 Appetite decreased/ 
Anorexia 
90 (39.5) 26 (11.4) 3.66 1.93-6.94 <0.001 
 Lethargy/ depressed 50 (21.9) 21 (9.2) 3.34 1.59-7.02 <0.001 
 Diarrhoea/Melaena 85 (37.3) 38 (16.7) 2.29 1.26-4.16 0.006 
*Stata firthlogit modelling used because of complete separation 
 
 
 
 
  
29 
 
29 
 
Figure 1. Kaplan-Meier survival curves for dogs diagnosed with CKD grouped by IRIS stage at 
diagnosis showing reducing survival with increasing IRIS stage.  
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Figure 2. Kaplan-Meier survival curves for dogs diagnosed with CKD grouped by blood urea 
nitrogen concentration (mg/dl) at diagnosis showing reducing survival with increasing blood 
urea nitrogen concentration.  
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Table 4. Final multivariable Cox regression model for risk factors associated with death among 
primary veterinary practice dogs diagnosed with chronic kidney disease 
Risk Factor No. cases (%) Hazard Ratio 95% CI P-value 
Iris stage at diagnosis     
 1 or 2 41 (30.1) Referent Referent Referent 
 3 65 (47.8) 2.62 1.14-6.01 0.023 
 4 30 (22.1) 4.71 1.74-12.72 0.002 
Blood Urea at diagnosis (mg/dl) 
    
 Less than 44.8 33 (23.7) Referent Referent Referent 
 44.8 to less than 64.4 37 (26.6) 1.24 0.48-3.16 0.659 
 64.4 to less than 112.0 32 (23.0) 2.60 0.98-6.90 0.055 
 112.0 and above 37 (26.6) 7.76 2.65-22.74 <0.001 
 
 
 
 
 
 
 
 
 
